At a glance
- Originator Yung-Jin Pharmaceutical
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Peptic ulcer
Most Recent Events
- 22 Mar 1999 Preclinical development for Peptic ulcer in Japan (PO)